Literature DB >> 12907595

Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.

Göran Hesselager1, Lene Uhrbom, Bengt Westermark, Monica Nistér.   

Abstract

INK4a-ARF and p53 inactivation are common but rarely concurrent findings in glioblastoma multiforme. Here we demonstrate that experimental deletion of either tumor suppressor gene cooperates with retrovirally expressed platelet-derived growth factor (PDGF)-B regarding both tumor latency and frequency in a mouse brain tumor model. We find indications of PTEN down-regulation and increased Akt phosphorylation in both types of null tumors (although more prominent in p53-/- tumors) suggesting a possible mechanism for this synergism. This is the first time that the cooperative tumorigenic effects of PDGF-B stimulation and p53 loss of function are demonstrated in an in vivo model, establishing a functional link between two common molecular changes of human secondary glioblastoma multiforme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907595

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.

Authors:  Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose-Manuel Garcia-Verdugo; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis.

Authors:  Lorin E Olson; Philippe Soriano
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

Review 3.  The interface between glial progenitors and gliomas.

Authors:  Peter Canoll; James E Goldman
Journal:  Acta Neuropathol       Date:  2008-09-11       Impact factor: 17.088

4.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.

Authors:  Y Murakami; K Saigo; H Takashima; M Minami; T Okanoue; C Bréchot; P Paterlini-Bréchot
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 5.  Review: insights gained from modelling high-grade glioma in the mouse.

Authors:  S L Rankin; G Zhu; S J Baker
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

6.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.

Authors:  Yuan Zhu; Frantz Guignard; Dawen Zhao; Li Liu; Dennis K Burns; Ralph P Mason; Albee Messing; Luis F Parada
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

7.  p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells.

Authors:  Brenton R Paolella; Matthew C Havrda; Akio Mantani; Christina M Wray; Zhonghua Zhang; Mark A Israel
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

Review 8.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

9.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

Review 10.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.